Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel norepinephrine and serotonin reuptake inhibitors imparted by Pfizer

July 4, 2006

Zerenex shows utility as treatment for hyperphosphatemia in hemodialysis patients

July 3, 2006

No safety concerns in phase II BPH study of NX-1207

June 30, 2006

End of phase II meeting for Anturol

June 29, 2006

Schering AG terminates Alprox-TD license with NexMed

June 29, 2006

AEterna Zentaris to advance cetrorelix into phase III for BPH

June 23, 2006

New fixed-dose formulations for BPH described in recent GSK patent

June 22, 2006

Toray granted Japanese license to AC-200

June 21, 2006

Sanctura XR reduces symptoms of overactive bladder

June 19, 2006

Pfizer completes acquisition of fesoterodine rights from Schwarz Pharma

June 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...